97410265
May 13, 2022
Biological preparations, namely, gene therapies based on engineered viral vectors, for preventing, managing and treating diseases and disorders of the liver, heart, skeletal muscle, ear, eye, peripheral and central nervous systems; Biological components in the nature of enveloped or membrane-associated viral vectors used for the delivery of therapeutic agents to targeted cells within the human body; Biological components in the nature of engineered viral vectors used for the delivery of therapeutic agents to targeted cells within the human body; Biological components, namely, viral vectors, being a component in therapeutic preparations for use in diseases and disorders of the liver, heart, skeletal muscle, ear, eye, peripheral and central nervous systems; Therapeutic agents and gene therapies based on engineered viral vectors for the treatment of diseases and disorders of the liver, heart, skeletal muscle, ear, eye, peripheral and central nervous system
PharmaceuticalsResearch and development in the fields of gene therapy based on engineered viral vectors, enveloped or membrane-associated viral vectors and engineered viral vectors; Providing scientific testing services in the medical fields of gene therapy based on engineered viral vectors, enveloped or membrane-associated viral vectors and engineered viral vectors; Providing medical scientific research information in the fields of gene therapy based on engineered viral vectors, enveloped or membrane-associated viral vectors and engineered viral vectors
Computer and Scientific